Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antibodies Neutralizing
16%
Autoantibodies
16%
B Cells
33%
Biological Evaluation
16%
CD4+
16%
CD8+
16%
Clinical Assessment
16%
Clinical Parameters
16%
Composition Effect
100%
Convalescent Plasma
100%
Convalescent Plasma Therapy
16%
COVID-19
100%
Cytokine Profile
16%
Effector Memory
16%
Fatty Acyls
16%
Glycerophospholipids
16%
Hospitalized Patients
16%
Immune Response
16%
Immunoglobulin G
16%
Immunological Effects
100%
Interleukin-10
33%
Interleukin-6
50%
IP-10
16%
Latent Autoimmunity
16%
Lipidomic Profile
16%
Mechanism of Action
16%
Memory B Cells
16%
Memory CD4+ T Cells
16%
Metabolite Profile
16%
Metabolomics
16%
Nave
16%
Neutralizing Antibodies
33%
Nineteen
16%
Pandemic Control
16%
Phase Control
16%
Plasma Composition
100%
Plasma-induced
16%
Posttransfusion
16%
Pre-pandemic
16%
Profile Modification
16%
Recovered COVID-19 Patients
16%
Recovered Patients
50%
SARS-CoV-2 Antibodies
50%
Severe Disease
33%
Severe Patients
100%
T Cells
33%
Therapeutic Implications
16%
Total IgA
16%
Total IgE
16%
Total Immunoglobulin
16%
Viral Load
16%
Immunology and Microbiology
Autoantibody
12%
Autoimmunity
12%
B Cell
25%
Blood Plasma
100%
CD4
12%
CD8
12%
COVID-19
100%
Cytokine
25%
Immune Response
12%
Immunoglobulin A
25%
Immunoglobulin G
12%
Interleukin 10
25%
Interleukin 6
37%
Memory B Cell
12%
Neutralizing Antibody
25%
Severe Acute Respiratory Syndrome Coronavirus 2
37%
T Cell
25%
T-Helper Cell
12%
Viral Load
12%